Yan Xue, Baolan Wan, Zhen Wang, Zhiwei Wang, Dongzhi Wang, Wanping Yang, Xueting Wang, Li Zhu
{"title":"Hydroxychloroquine Prevents High-altitude Cerebral Edema by Inhibiting Endothelial Claudin-5 Autophagic Degradation.","authors":"Yan Xue, Baolan Wan, Zhen Wang, Zhiwei Wang, Dongzhi Wang, Wanping Yang, Xueting Wang, Li Zhu","doi":"10.2174/011570159X371235250417051313","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>High-altitude cerebral edema (HACE) is a serious condition caused by pro-longed hypobaric hypoxia (HH). Autophagic degradation of Claudin-5 plays a crucial role in HH-induced blood-brain barrier (BBB) damage. Hydroxychloroquine (HCQ), a lysosomal inhibitor used in autophagy treatment, reduces inflammation and BBB damage in traumatic brain injury. However, its effectiveness in preventing HACE is still unknown.</p><p><strong>Methods: </strong>C57BL/6J mice were treated with HCQ and exposed to HH for 24 hrs to study BBB integ-rity. We evaluated BBB disruption via brain water content, Evans blue, and FITC-dextran assays. Changes in tight junctions (TJs) of cerebrovascular endothelial cells were analyzed using electron microscopy and immunofluorescence. Western blotting quantified autophagy protein levels in brain tissue. Hypoxia-mimetic in vitro models were used to explore HCQ's effects on TJs and BBB per-meability, confirmed by various assays, including immunofluorescence, electron microscopy, and Western blotting.</p><p><strong>Results: </strong>HCQ significantly mitigated rapamycin-induced autophagy and Claudin-5 degradation. Pro-longed hypoxia exposure promoted lysosomal degradation of Claudin-5, increasing endothelial cell permeability. HCQ inhibited autophagy in bEnd.3 cells via the PI3K-Akt-mTOR and Erk pathway, reducing hypoxia-induced Claudin-5 down-regulation. In mice, HH exposure increased brain au-tophagy, damaging the vascular endothelial TJs and subsequently increasing endothelial permeabil-ity. Pretreatment with HCQ significantly reduced the level of autophagy in the brains of HH-exposed mice, thereby mitigating the HH-induced damage to vascular TJs, alleviating the downregulation of Claudin-5, and enhancing endothelial integrity.</p><p><strong>Conclusion: </strong>HCQ effectively prevented HACE by inhibiting HH-induced Claudin-5 membrane ex-pression downregulation, thus mitigating BBB damage and brain water content increase in HH-exposed mice.</p>","PeriodicalId":10905,"journal":{"name":"Current Neuropharmacology","volume":" ","pages":""},"PeriodicalIF":4.8000,"publicationDate":"2025-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Neuropharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/011570159X371235250417051313","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Background: High-altitude cerebral edema (HACE) is a serious condition caused by pro-longed hypobaric hypoxia (HH). Autophagic degradation of Claudin-5 plays a crucial role in HH-induced blood-brain barrier (BBB) damage. Hydroxychloroquine (HCQ), a lysosomal inhibitor used in autophagy treatment, reduces inflammation and BBB damage in traumatic brain injury. However, its effectiveness in preventing HACE is still unknown.
Methods: C57BL/6J mice were treated with HCQ and exposed to HH for 24 hrs to study BBB integ-rity. We evaluated BBB disruption via brain water content, Evans blue, and FITC-dextran assays. Changes in tight junctions (TJs) of cerebrovascular endothelial cells were analyzed using electron microscopy and immunofluorescence. Western blotting quantified autophagy protein levels in brain tissue. Hypoxia-mimetic in vitro models were used to explore HCQ's effects on TJs and BBB per-meability, confirmed by various assays, including immunofluorescence, electron microscopy, and Western blotting.
Results: HCQ significantly mitigated rapamycin-induced autophagy and Claudin-5 degradation. Pro-longed hypoxia exposure promoted lysosomal degradation of Claudin-5, increasing endothelial cell permeability. HCQ inhibited autophagy in bEnd.3 cells via the PI3K-Akt-mTOR and Erk pathway, reducing hypoxia-induced Claudin-5 down-regulation. In mice, HH exposure increased brain au-tophagy, damaging the vascular endothelial TJs and subsequently increasing endothelial permeabil-ity. Pretreatment with HCQ significantly reduced the level of autophagy in the brains of HH-exposed mice, thereby mitigating the HH-induced damage to vascular TJs, alleviating the downregulation of Claudin-5, and enhancing endothelial integrity.
Conclusion: HCQ effectively prevented HACE by inhibiting HH-induced Claudin-5 membrane ex-pression downregulation, thus mitigating BBB damage and brain water content increase in HH-exposed mice.
期刊介绍:
Current Neuropharmacology aims to provide current, comprehensive/mini reviews and guest edited issues of all areas of neuropharmacology and related matters of neuroscience. The reviews cover the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience.
The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.